Robigo is a Cambridge, Massachusetts-based agricultural biotechnology company that engineers microbes to protect crops from fungal disease. Its proprietary ARGO platform computationally designs the active ingredients that its engineered, shelf-stable microbes continuously produce and deliver in the field as a one-time seed treatment. Two products are gearing up for commercial launch in the United States - a soybean sudden death syndrome seed treatment slated for 2028 and a fusarium wilt treatment for lettuce and berries slated for 2029 - with pipeline expansion planned into soil-borne pathogens in broad-acre crops.
1
Round
1
Industry
3
Tags
Sep 18, 2026
Latest raise
Funding activity · 1 round
Sep 18, 2026
Series A
Led by Leaps by Bayer
Robigo Closes Series A Robigo, a Cambridge, Massachusetts based agricultural biotechnology company, has raised a Series A round. The round was led by Leaps by…
Read articlePricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
